Step Capital Management’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
TP
Step Capital Management's MRNA Position: Q3 2026 in Review
Step Capital Management increased its Moderna (MRNA) stake by 1.4% in Q3 2026, buying an estimated $1.08M and bringing the position to 705,000 shares worth $136M. The position accounts for 53.92% of the portfolio, ranked #1.
Step Capital Management first reported a position in MRNA in Q4 2025 and has held it in 4 quarters since. 1,048 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.
- Step Capital Management held 705,000 shares of Moderna worth $136M as of Q3 2026.
- Step Capital Management bought 10,000 Moderna shares in Q3 2026, an estimated $1.08M.
- Moderna made up 53.92% of Step Capital Management's portfolio in Q3 2026, its #1 holding.
- Step Capital Management first reported a position in Moderna in Q4 2025 and has held it in 4 quarters since.
- 1,048 funds tracked by Wall St. Rank held Moderna as of Q3 2026.
Based on Step Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.